• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

少尿和无尿持续时间作为腹泻后溶血尿毒综合征慢性肾脏相关后遗症的预测指标

Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.

作者信息

Oakes Robert S, Kirkham Justin K, Nelson Raoul D, Siegler Richard L

机构信息

Division of Nephrology and Hypertension, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA.

出版信息

Pediatr Nephrol. 2008 Aug;23(8):1303-8. doi: 10.1007/s00467-008-0799-9. Epub 2008 May 9.

DOI:10.1007/s00467-008-0799-9
PMID:18465151
Abstract

Prior long-term retrospective studies have described renal sequelae in 25-50% of postdiarrheal hemolytic uremic syndrome (HUS) survivors, but the ability to predict the likelihood of chronic renal-related sequelae at the time of hospital discharge is limited. We surveyed 357 children in our HUS registry who survived an acute episode of post diarrheal HUS (D+HUS) and were without end-stage renal disease (ESRD) at the time of hospital discharge. Of the 357 patients surveyed, 159 had at least 1 year (mean 8.75 years) of follow-up. Of these, 90 individuals were identified as having had at least 1 day of oliguria, with 69 individuals having had at least 1 day of anuria. The incidences of renal-related sequelae [proteinuria, low glomerular filtration rate (GFR), and hypertension] were determined among experimental groups based on oliguria and anuria duration. One or more sequelae (e.g. proteinuria, low GFR, hypertension) was seen in 25 (36.2%) of those who had no recorded oliguria and 34 (37.8%) of those with no recorded anuria. The prevalence of chronic sequelae increased markedly in those with more than 5 days of anuria or 10 days of oliguria, with anuria being a better predictor than oliguria of most related sequelae. A particularly high incidence of hypertension was seen in patients with > 10 days of anuria (55.6%) in comparison with those with no anuria (8.9%) [odds ratio (OR) 12.8; 95% confidence interval (CI) 2.9-57.5]. Patients with > 10 days of anuria were also at substantially increased risk for low GFR and proteinuria (OR 35.2; 95% CI 5.1-240.5). These findings may help identify children who need periodic and extended follow-up after hospital discharge.

摘要

既往长期回顾性研究表明,25%-50%的腹泻后溶血尿毒综合征(HUS)幸存者会出现肾脏后遗症,但在出院时预测慢性肾脏相关后遗症可能性的能力有限。我们对357名在我们HUS登记处登记的儿童进行了调查,这些儿童均度过了腹泻后HUS(D+HUS)的急性发作期,且出院时未患有终末期肾病(ESRD)。在接受调查的357名患者中,159名患者至少有1年(平均8.75年)的随访时间。其中,90人被确定至少有1天少尿,69人至少有1天无尿。根据少尿和无尿持续时间,在各实验组中确定肾脏相关后遗症(蛋白尿、低肾小球滤过率(GFR)和高血压)的发生率。在无少尿记录的患者中,25人(36.2%)出现了一种或多种后遗症(如蛋白尿、低GFR、高血压);在无无尿记录的患者中,34人(37.8%)出现了一种或多种后遗症。无尿超过5天或少尿超过10天的患者中,慢性后遗症的患病率显著增加,对于大多数相关后遗症而言,无尿比少尿是更好的预测指标。与无无尿的患者(8.9%)相比,无尿超过10天的患者高血压发生率特别高(55.6%)[比值比(OR)12.8;95%置信区间(CI)2.9-57.5]。无尿超过10天的患者发生低GFR和蛋白尿的风险也大幅增加(OR 35.2;95%CI 5.1-240.5)。这些发现可能有助于识别出院后需要定期和长期随访的儿童。

相似文献

1
Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.少尿和无尿持续时间作为腹泻后溶血尿毒综合征慢性肾脏相关后遗症的预测指标
Pediatr Nephrol. 2008 Aug;23(8):1303-8. doi: 10.1007/s00467-008-0799-9. Epub 2008 May 9.
2
Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.基于人群的队列研究显示,腹泻相关性溶血尿毒综合征的长期预后与 1 年随访时的肾脏损伤标志物相关性差。
Pediatr Nephrol. 2019 Apr;34(4):657-662. doi: 10.1007/s00467-018-4131-z. Epub 2018 Oct 27.
3
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
4
Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.2011 年肠出血性大肠杆菌 O104:H4 引起的小儿溶血尿毒综合征的中期随访。
Clin Infect Dis. 2017 Jun 15;64(12):1637-1643. doi: 10.1093/cid/cix218.
5
Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.挪威儿童溶血尿毒综合征的临床特征、治疗干预及长期情况:一项1999年至2008年的全国性回顾性研究
BMC Infect Dis. 2016 Jun 13;16:285. doi: 10.1186/s12879-016-1627-7.
6
[Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].[腹泻后溶血性尿毒症综合征:何时应予以考虑?如何进行随访?]
Arch Pediatr. 2011 Jul;18(7):823-30. doi: 10.1016/j.arcped.2011.04.001. Epub 2011 May 14.
7
Long-term outcomes of Shiga toxin hemolytic uremic syndrome.志贺毒素溶血尿毒综合征的长期预后。
Pediatr Nephrol. 2013 Nov;28(11):2097-105. doi: 10.1007/s00467-012-2383-6. Epub 2013 Jan 4.
8
A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah.一项基于犹他州人群的为期20年的腹泻后溶血性尿毒症综合征研究。
Pediatrics. 1994 Jul;94(1):35-40.
9
Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome.
J Pediatr. 1991 Feb;118(2):195-200. doi: 10.1016/s0022-3476(05)80482-2.
10
CHARACTERISTICS OF DIARRHEAL DISEASE COMPLICATED WITH HEMOLYTIC UREMIC SYNDROME AMONG CHILDREN IN GEORGIA, 2009-2016.2009 - 2016年格鲁吉亚儿童腹泻病合并溶血尿毒综合征的特征
Georgian Med News. 2018 Oct(283):123-129.

引用本文的文献

1
Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.一项开放标签、对照的2期临床试验,评估INM004在产志贺毒素大肠杆菌相关溶血尿毒综合征儿科患者中的安全性、有效性和药代动力学。
Pediatr Nephrol. 2025 Jun;40(6):1983-1995. doi: 10.1007/s00467-024-06583-3. Epub 2024 Nov 12.
2
Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up.产志贺毒素大肠埃希菌(STEC)相关性溶血尿毒综合征 10 年后的结局:长期随访的重要性。
Pediatr Nephrol. 2024 Aug;39(8):2459-2465. doi: 10.1007/s00467-024-06355-z. Epub 2024 Apr 9.
3

本文引用的文献

1
A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension.对糖尿病和高血压患者微量白蛋白尿与心血管事件之间关系的结构化综述。
Pharmacotherapy. 2003 Dec;23(12):1611-6. doi: 10.1592/phco.23.15.1611.31962.
2
Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.对患有D+型溶血性尿毒症综合征的捷克儿童的长期随访。
Pediatr Nephrol. 2002 Jun;17(6):400-3. doi: 10.1007/s00467-002-0836-z.
3
National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification.
Kidney sequelae in 281 Shiga toxin-producing Escherichia coli-hemolytic uremic syndrome patients after a median follow-up of 12 years.281 例志贺毒素产大肠埃希菌溶血尿毒综合征患者 12 年中位随访后的肾脏后遗症。
Pediatr Nephrol. 2024 Apr;39(4):1221-1228. doi: 10.1007/s00467-023-06183-7. Epub 2023 Oct 26.
4
Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study.儿童溶血尿毒综合征:英格兰、威尔士、北爱尔兰和爱尔兰的前瞻性队列研究。
Epidemiol Infect. 2023 Sep 1;151:e160. doi: 10.1017/S0950268823001413.
5
Long-term kidney outcomes in non-dialyzed children with Shiga-toxin Escherichia coli associated hemolytic uremic syndrome.非透析治疗的志贺毒素大肠杆菌相关性溶血尿毒综合征患儿的长期肾脏结局。
Pediatr Nephrol. 2023 Jul;38(7):2131-2136. doi: 10.1007/s00467-022-05851-4. Epub 2023 Jan 3.
6
Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.产志贺毒素大肠埃希菌引起的儿童溶血尿毒综合征:发病率、危险因素和临床结局。
Pediatr Nephrol. 2020 Sep;35(9):1749-1759. doi: 10.1007/s00467-020-04560-0. Epub 2020 Apr 22.
7
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.志贺毒素相关性溶血尿毒综合征:一篇叙述性综述。
Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067.
8
Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.预测产志贺毒素大肠杆菌感染儿童的溶血尿毒综合征及肾脏替代治疗
Clin Infect Dis. 2020 Apr 10;70(8):1643-1651. doi: 10.1093/cid/ciz432.
9
Prevalence and factors associated with renal dysfunction in children admitted to two hospitals in northwestern Tanzania.坦桑尼亚西北部两家医院收治儿童的肾功能障碍的流行情况及其相关因素。
BMC Nephrol. 2019 Mar 5;20(1):79. doi: 10.1186/s12882-019-1254-9.
10
Risk Factors for Short- and Long-Term Outcomes in Children With STEC-HUS/D HUS: A Single-Center Experience.产志贺毒素大肠杆菌溶血尿毒综合征/腹泻性溶血尿毒综合征患儿短期和长期预后的危险因素:单中心经验
Glob Pediatr Health. 2018 Dec 4;5:2333794X18816920. doi: 10.1177/2333794X18816920. eCollection 2018.
美国国家肾脏基金会慢性肾脏病指南:评估、分类及分层
J Am Acad Nurse Pract. 2002 Jun;14(6):238-42. doi: 10.1111/j.1745-7599.2002.tb00119.x.
4
[Post-diarrhea hemolytic-uremic syndrome: clinical aspects].[腹泻后溶血尿毒综合征:临床方面]
Arch Pediatr. 2001 Sep;8 Suppl 4:776s-784s. doi: 10.1016/s0929-693x(01)80196-2.
5
[Changing clinical course of hemolytic uremic syndrome in children].[儿童溶血性尿毒症综合征的临床病程变化]
Pol Merkur Lekarski. 2000 Apr;8(46):234-5.
6
Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE).儿童蛋白尿和肾病综合征的评估与管理:美国国家肾脏基金会蛋白尿、白蛋白尿、风险、评估、检测及消除会议(PARADE)设立的儿科肾脏病学小组的建议
Pediatrics. 2000 Jun;105(6):1242-9. doi: 10.1542/peds.105.6.1242.
7
Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow.溶血尿毒综合征的长期预后与有效肾血浆流量
Pediatr Nephrol. 1999 Oct;13(8):672-7. doi: 10.1007/s004670050679.
8
[Uremic hemolytic syndrome. Analysis of 43 cases].[尿毒症性溶血性综合征。43例分析]
An Esp Pediatr. 1999 May;50(5):467-70.
9
Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features.阿根廷儿童溶血性尿毒症综合征:长期随访及预后特征
Pediatr Nephrol. 1997 Apr;11(2):156-60. doi: 10.1007/s004670050248.
10
Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome.溶血性尿毒症综合征中局灶节段性硬化和玻璃样变的发展
Pediatr Nephrol. 1996 Dec;10(6):687-92. doi: 10.1007/s004670050189.